Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II–dependent hypertension-Reference-Cited by-同舟云学术

Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II–dependent hypertension

Published:2016-04 Issue:4 Volume:10 Page:346-351
ISSN:1933-1711
Container-title:Journal of the American Society of Hypertension
language:en
Short-container-title:Journal of the American Society of Hypertension

Author:

Stec David E.,Juncos Luis A.,Granger Joey P.

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Reference36 articles.

1. Sex-specific effects of heme oxygenase-2 deficiency on renovascular hypertension;Stout;J Am Soc Hypertens,2013

2. Pharmacological and clinical aspects of heme oxygenase;Abraham;Pharmacol Rev,2008

3. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure;Li;Hypertension,2007

4. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats;Sacerdoti;Science,1989

5. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice;Vera;Am J Physiol Regul Integr Comp Physiol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID ‐19 and associated comorbid conditions;Phytotherapy Research;2022-04-08

2. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors;Clinical and Experimental Hypertension;2020-05-13

3. The Effects of Heme Oxygenase Upregulation on Obesity and the Metabolic Syndrome;Antioxidants & Redox Signaling;2020-05-10

4. Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease;Antioxidants;2019-06-18

5. Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation;The Pharmacogenomics Journal;2019-02-06